Research Topics
| C NiederauSummaryAffiliation: Heinrich Heine University Country: Germany Publications
| Collaborators
|
Detail Information
Publications
The role of calcium in pancreatitisC Niederau
Department of Internal Medicine, St Josef Hospital Oberhausen, Germany
Hepatogastroenterology 46:2723-30. 1999..So far, [Ca2+]i increases were thought to represent physiological signals when they occurred as oscillations at the single cell level...
[Diagnosis and therapy of Gaucher disease. Current recommendations of German therapy centers in the year 2000]C Niederau
Klinik fur Innere Medizin, St Josef Hospital Oberhausen, Akademisches Lehrkrankenhaus, Universitat Essen
Med Klin (Munich) 96:32-9. 2001..In 5 to 10% of the patients there are also central nervous symptoms such as myoclonic seizures, oculomotoric apraxia and a slight mental retardation...
[Diabetes mellitus in hemochromatosis]C Niederau
Innere Abteilung, St Josef Hospital Oberhausen, Akademisches Lehrkrankenhaus der Universität Essen
Z Gastroenterol . 1999..Thus, in the future we should aim to diagnose hemochromatosis in early stages which are not associated with diabetes mellitus or liver cirrhosis...
Role of cholecystokinin in the development and progression of acute pancreatitis and the potential of therapeutic application of cholecystokinin receptor antagonistsC Niederau
St Josef Hospital, Academic Teaching Hospital, Department of Internal Medicine, Oberhausen, Germany
Digestion 60:69-74. 1999..There is also evidence that CCK antagonists have a potential therapeutic benefit. Clinical studies will evaluate their therapeutic potential for patients with AP...
Prognosis of chronic hepatitis C: results of a large, prospective cohort studyC Niederau
Department of Medicine, Division of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich Heine Universitat Dusseldorf, Dusseldorf, Germany
Hepatology 28:1687-95. 1998..The age at diagnosis therefore should play a major role in therapeutic considerations. The present data also suggest that interferon therapy has a long-term clinical benefit, although it did not reduce the risk of liver cancer...
Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study GroupC Niederau
Department of Medicine, Heinrich Heine University of Dusseldorf, Germany
Hepatogastroenterology 45:797-804. 1998..The diagnosis of chronic viral hepatitis was based on an abnormal serum alanine aminotransferase (ALT) value (more than twice the upper value of normal), viral replication and chronic hepatitis found on liver biopsy...
First long-term results of imiglucerase therapy of type 1 Gaucher diseaseC Niederau
Department of Medicine, Heinrich Heine Universitat, Dusseldorf, Germany
Eur J Med Res 3:25-30. 1998..This case report, with 30 months' follow-up, represents the first publication of long-term results of imiglucerase therapy of type 1 Gaucher's disease in Europe...
CCK-resistance in Zucker obese versus lean ratsC Niederau
Department of Medicine, Heinrich Heine University, Dusseldorf, Germany
Regul Pept 70:97-104. 1997..However, the failure of the CCK-A antagonist to increase food intake questions whether any of the effects of exogenous CCK are of physiological relevance...
[Diagnosis and treatment of chronic hepatitis C. Practical recommendations and new developments]C Niederau
Klinik fur Innere Medizin, St Josef Hospital Oberhausen, Akademisches Lehrkrankenhaus, Universitat Essen
Med Klin (Munich) 96:599-607. 2001..Chronic hepatitis C affects more than 500,000 people in Germany and is one of the most important chronic liver diseases. A large part of liver cirrhosis and cancer as well as most liver transplantations are today caused by hepatitis C...
Gaucher's disease: a review for the internist and hepatologistC Niederau
Department of Medicine, St Josef Hospital Oberhausen, University of Essen, Germany
Hepatogastroenterology 47:984-97. 2000..Regression of skeletal complications is usually seen only after 3-4 years. Recently gene therapy trials, which center on autotransfusion of retrovirally transduced stem cells, have successfully been started...
Safety, tolerability and efficacy of peginterferon alpha-2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety TrialTh Witthöft
Medical Department I, Division of Gastroenterology, University Hospital Schleswig Holstein Campus Lübeck, Lubeck, Germany
J Viral Hepat 14:788-96. 2007..This investigation confirms the well-known risk-benefit ratio found in controlled studies in a clinical practice setting. The safety profile is similar and shows the highest incidence of adverse events in the first 12 weeks of treatment...
Epidemiology, clinical spectrum and prognosis of hemochromatosisC Niederau
Dept of Medicine, Heinrich Heine University of Dusseldorf, Germany
Adv Exp Med Biol 356:293-302. 1994..Further strategies have to evaluate the design of screening programs in order to diagnose more patients in the precirrhotic and asymptomatic stage...
Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis BA Erhardt
Department of Internal Medicine, Division of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich Heine University of Dusseldorf, Dusseldorf, Germany
Hepatology 31:716-25. 2000..Our data suggest that HBV genome mutations located within the BCP are determinants of a response to IFN therapy...
[Changes in socio-economics, quality of life and knowledge of patients with chronic hepatitis C during the Hepatitis Competence Net Project]C Niederau
Katholische Kliniken Oberhausen GmbH, St Josef Hospital, Akademisches Lehrkrankenhaus der Universität Duisburg Essen, Oberhausen
Z Gastroenterol 46:22-33. 2008..A 1st questionnaire 3 1/2 years ago gathered information in 714 CHC patients all of whom now received a 2nd questionnaire which was sent back by 503 subjects (71%)...
[Gaucher disease: MR evaluation of bone marrow features during treatment with enzyme replacement]L W Poll
Institut für Diagnostische Radiologie, Heinrich Heine Universitat Dusseldorf, Germany
Rofo 173:931-7. 2001..There are only a few studies available evaluating bone disease during ERT. The aim of this study was to investigate the features of bone marrow (bm) by magnetic resonance imaging (MRI) in these patients during ERT...
Hepatosplenomegalic lipidosis: what unless Gaucher? Adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitotriosidase activity and a homozygous lysosomal acid lipase -1 exon 8 splice junction mutationS Vom Dahl
Division of Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University, Dusseldorf, Germany
J Hepatol 31:741-6. 1999..Based on clinical, laboratory, cytological and and biochemical findings, CESD can clearly be separated from other more frequent inherited lysosomal storage diseases, e.g. atypical forms of Gaucher disease...
[New data and recommendations of antiviral therapy of chronic hepatitis B and C]C Niederau
Klinik fur Innere Medizin, St Josef Hospital, Katholische Kliniken Oberhausen gGmbH, Akademisches Lehrkrankenhaus der Universität Duisburg Essen, Mülheimer Strasse 83, 46045, Oberhausen, Deutschland
Internist (Berl) 49:1265-6, 1268-73. 2008..Without such rapid response HCV-RNA needs to be checked after 12 and 24 weeks: when HCV-RNA becomes negative only after 24 weeks, a prolongation of therapy might be advisable...
[Hereditary hemochromatosis]C Niederau
St Josef Hospital, Oberhausen
Internist (Berl) 44:191-205; quiz 206-7. 2003..The prognosis of haemochromatosis is normal when phlebotomy therapy is started prior to manifestation of cirrhosis or diabetes. Screening strategies should be implemented to improve early detection...
Clinical spectrum and management of haemochromatosisC Niederau
Medizinische Klinik und Poliklinik, Abteilung für Gastroenterologie, Heinrich Heine Universitat Dusseldorf, Germany
Baillieres Clin Haematol 7:881-901. 1994..Further strategies have to evaluate the design of screening programmes in order to diagnose more patients in the precirrhotic and asymptomatic stage...
